LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Considering a Biologic: What's a Clinician to Do? Screening and Laboratory Monitoring for Biologic Therapies in the Treatment of Psoriasis.

    Jin, Annie / Zaladonis, Angela G / Hsu, Sylvia

    Skinmed

    2022  Volume 20, Issue 1, Page(s) 14–17

    Abstract: Biologic therapies have revolutionized the treatment of psoriasis; however, these immunomodulatory therapies may increase the risk of reactivation of latent and chronic infections. Tumor necrosis factor alpha (TNF-α) inhibitors, in particular, have been ... ...

    Abstract Biologic therapies have revolutionized the treatment of psoriasis; however, these immunomodulatory therapies may increase the risk of reactivation of latent and chronic infections. Tumor necrosis factor alpha (TNF-α) inhibitors, in particular, have been associated with the increased risk of reactivation of tuberculosis (TB) in patients with latent TB, as well as hepatitis B virus (HBV), in patients with chronic HBV infections. Currently, baseline TB tests are the only screening tests supported with strong evidence. High-grade evidence for HBV screening tests is lacking; however, these tests are sometimes performed in clinical practice. We describe current recommendations for screening tests prior to the initiation of biologic therapy.
    MeSH term(s) Biological Therapy ; Hepatitis B virus/physiology ; Humans ; Immunologic Factors/therapeutic use ; Latent Tuberculosis/complications ; Latent Tuberculosis/diagnosis ; Psoriasis/complications ; Psoriasis/drug therapy ; Tumor Necrosis Factor-alpha
    Chemical Substances Immunologic Factors ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2022-02-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2171125-2
    ISSN 1751-7125 ; 1540-9740
    ISSN (online) 1751-7125
    ISSN 1540-9740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Facial Discoid Dermatosis: What Is It?

    Zaladonis, Angela G / Lee, Jason B / Hsu, Sylvia / Motaparthi, Kiran

    Skinmed

    2022  Volume 20, Issue 3, Page(s) 174–176

    MeSH term(s) Humans ; Skin Diseases
    Language English
    Publishing date 2022-06-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2171125-2
    ISSN 1751-7125 ; 1540-9740
    ISSN (online) 1751-7125
    ISSN 1540-9740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Painful Abdominal Outpouching in an Adult Male.

    Zaladonis, Angela G / Applebaum, Danielle / Hsu, Sylvia

    Cureus

    2021  Volume 13, Issue 1, Page(s) e12416

    Abstract: Post-herpetic abdominal pseudohernia is a neurologic complication of herpes zoster resulting from paresis of the abdominal wall muscles ipsilateral to the eruption. This poorly known condition may raise suspicion for true abdominal wall hernia or other ... ...

    Abstract Post-herpetic abdominal pseudohernia is a neurologic complication of herpes zoster resulting from paresis of the abdominal wall muscles ipsilateral to the eruption. This poorly known condition may raise suspicion for true abdominal wall hernia or other concerning etiologies, resulting in extensive work-up and imaging. Post-herpetic abdominal pseudohernia is a relatively benign condition, which resolves spontaneously in the majority of cases. Therefore, it is important for the clinician to be aware of this complication in order to avoid unnecessary imaging or excessive management, which may increase the cost of care and burden to the patient.
    Language English
    Publishing date 2021-01-01
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.12416
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Considering a Biologic: What's a Clinician to Do? Management of Biologics in Surgery, Vaccinations, and Cancer.

    Jin, Annie / Zaladonis, Angela G / Hsu, Sylvia

    Skinmed

    2021  Volume 19, Issue 1, Page(s) 17–19

    Abstract: In the past two decades, biologic therapy has become ubiquitous in the treatment of psoriasis; however, important considerations should be taken with regard to biologic use in the context of surgery, vaccinations, and cancers. With conflicting evidence ... ...

    Abstract In the past two decades, biologic therapy has become ubiquitous in the treatment of psoriasis; however, important considerations should be taken with regard to biologic use in the context of surgery, vaccinations, and cancers. With conflicting evidence on the effects of perioperative biologic use, we recommend withholding tumor necrosis factor alpha (TNF-α) inhibitor therapy for one dose prior to surgical procedures.
    MeSH term(s) Biological Products/administration & dosage ; Biological Products/adverse effects ; Biological Therapy/adverse effects ; Biological Therapy/methods ; Humans ; Neoplasms/pathology ; Neoplasms/therapy ; Perioperative Care/methods ; Psoriasis/drug therapy ; Psoriasis/pathology ; Tumor Necrosis Factor Inhibitors/administration & dosage ; Tumor Necrosis Factor Inhibitors/adverse effects ; Vaccines/administration & dosage ; Vaccines/adverse effects
    Chemical Substances Biological Products ; Tumor Necrosis Factor Inhibitors ; Vaccines
    Language English
    Publishing date 2021-02-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2171125-2
    ISSN 1751-7125 ; 1540-9740
    ISSN (online) 1751-7125
    ISSN 1540-9740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Indeterminate Cell Histiocytosis Mimicking Rosacea.

    Fischer, Andrew S / Zaladonis, Angela G / Subrt, Paul / Tschen, Jaime / Hsu, Sylvia

    Cureus

    2021  Volume 13, Issue 1, Page(s) e12850

    Abstract: Indeterminate cell histiocytosis (ICH) is a rare proliferative disorder of histiocytes, which display morphologic and immunophenotypic characteristics of both Langerhans cell histiocytosis (LCH) and non-Langerhans cell histiocytosis (NLCH). We describe ... ...

    Abstract Indeterminate cell histiocytosis (ICH) is a rare proliferative disorder of histiocytes, which display morphologic and immunophenotypic characteristics of both Langerhans cell histiocytosis (LCH) and non-Langerhans cell histiocytosis (NLCH). We describe an unusual clinical presentation of ICH mimicking rosacea and provide a relevant review of the literature.
    Language English
    Publishing date 2021-01-22
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.12850
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma.

    Hotz, Meghan J / O'Halloran, Eileen A / Hill, Maureen V / Hayden, Kelly / Zaladonis, Angela G / Deng, Mengying / Olszanski, Anthony J / Reddy, Sanjay S / Wu, Hong / Luo, Biao / Farma, Jeffrey M

    Melanoma research

    2022  Volume 32, Issue 2, Page(s) 112–119

    Abstract: Tumor mutational burden (TMB) has recently been identified as a biomarker of response to immune checkpoint inhibitors in many cancers, including melanoma. Co-assessment of TMB with inflammatory markers and genetic mutations may better predict disease ... ...

    Abstract Tumor mutational burden (TMB) has recently been identified as a biomarker of response to immune checkpoint inhibitors in many cancers, including melanoma. Co-assessment of TMB with inflammatory markers and genetic mutations may better predict disease outcomes. The goal of this study was to evaluate the potential for TMB and somatic mutations in combination to predict the recurrence of disease in advanced melanoma. A retrospective review of 85 patients with stage III or IV melanoma whose tumors were analyzed by next-generation sequencing was conducted. Fisher's exact test was used to assess differences in TMB category by somatic mutation status as well as recurrence locations. Kaplan-Meier estimates and Cox-proportional regression model were used for survival analyses. The most frequently detected mutations were TERT (32.9%), CDKN2A (28.2%), KMT2 (25.9%), BRAF V600E (24.7%), and NRAS (24.7%). Patients with TMB-L + BRAFWT status were more likely to have a recurrence [hazard ratio (HR), 3.43; confidence interval (CI), 1.29-9.15; P = 0.01] compared to TMB-H + BRAF WT. Patients with TMB-L + NRASmut were more likely to have a recurrence (HR, 5.29; 95% CI, 1.44-19.45; P = 0.01) compared to TMB-H + NRAS WT. TMB-L tumors were associated with local (P = 0.029) and in-transit (P = 0.004) recurrences. Analysis of TMB alone may be insufficient in understanding the relationship between melanoma's molecular profile and the body's immune system. Classification into BRAFmut, NRASmut, and tumor mutational load groups may aid in identifying patients who are more likely to have disease recurrence in advanced melanoma.
    MeSH term(s) Biomarkers, Tumor/genetics ; Humans ; Melanoma/pathology ; Mutation ; Neoplasm Recurrence, Local/genetics ; Proto-Oncogene Proteins B-raf/genetics ; Skin Neoplasms/pathology
    Chemical Substances Biomarkers, Tumor ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1)
    Language English
    Publishing date 2022-02-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 1095779-0
    ISSN 1473-5636 ; 0960-8931
    ISSN (online) 1473-5636
    ISSN 0960-8931
    DOI 10.1097/CMR.0000000000000808
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top